GenMont Biotech Incorporation announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 89.460 million compared to TWD 118.393 million a year ago. Operating income was TWD 19.430 million compared to TWD 43.364 million a year ago. Net income was TWD 15.956 million compared to TWD 36.193 million a year ago. Basic earnings per share was TWD 0.18 compared to TWD 0.41 a year ago. For the nine months, sales was TWD 266.788 million compared to TWD 311.921 million a year ago. Operating income was TWD 62.682 million compared to TWD 93.763 million a year ago. Net income was TWD 61.292 million compared to TWD 133.320 million a year ago. Basic earnings per share from continuing operations was TWD 0.69 compared to TWD 0.83 a year ago. Basic earnings per share was TWD 0.69 compared to TWD 1.5 a year ago. Diluted earnings per share was TWD 0.69 compared to TWD 1.49 a year ago.